G. Verleden (Leuven, Belgium), A. Boehler (Zurich, Switzerland)
Acid and non-acid reflux after lung transplantation. Impedance-pH monitoring in patients with and without pulmonary allograft dysfunction
K. Blondeau, J. Tack, G. M. Verleden, D. Sifrim, L. J. Dupont (Leuven, Belgium)
|   |
Evidence of increased gastric aspiration in acute lung allograft rejection
R. Stovold, I. A. Forrest, D. M. Murphy, P. A. Corris, A. J. Fisher, J. Dark, J. P. Pearson, I. A. Brownlee, J. A. Smith, S. Decalmer, C. Ward (Newcastle upon Tyne, Manchester, United Kingdom)
| |
Assessment of the Th1, Th2, Treg balance in lung transplantation
E. Mamessier, M. Badier, P. Thomas, A. Magnan, M. Reynaud-Gaubert (Marseille, France)
| |
Flow-cytometric detection of peripheral CD4+Foxp3+ Treg cells in lung transplant recipients
F. Meloni, M. Morosini, N. Solari, S. Miserere, A. Cascina, A. M. Fietta (Pavia, Italy)
| |
Does colonization with pseudomonas affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation?
G. M. Verleden, L. J. Dupont, B. M. Vanaudenaerde, D. E. Van Raemdonck (Leuven, Belgium)
| |
Hepatocyte growth factor – a link between neutrophilic inflammation and BOS?
I. A. Forrest, C. Ward, D. M. Murphy, D. Jones, G. E. Johnson, J. L. Lordan, T. E. Cawston, P. A. Corris (Newcastle upon Tyne, United Kingdom)
| |
Proteomic analysis of broncho alveolar lavage fluid (BAL-f) in lung transplant recipients (LTR) with bronchiolitis obliterans syndrome (BOS)
R. Salvini, I. Passadore, A. M. Bardoni, E. Pozzi, A. M. Fietta, F. Meloni (Pavia, Italy)
| |
Simvastatin potentially reduces airway neutrophilia & remodelling in lung allografts
D. M. Murphy, I. A. Forrest, C. Ward, P. A. Corris, D. Jones, G. E. Johnson, A. J. Fisher, J. J. Egan, T. E. Cawston, J. L. Lordan (Newcastle, United Kingdom; Dublin, Ireland)
| |